AbbVie
ABBV
2,983 hedge funds and large institutions have $162B invested in AbbVie in 2021 Q4 according to their latest regulatory filings, with 456 funds opening new positions, 1,280 increasing their positions, 921 reducing their positions, and 88 closing their positions.
418% more first-time investments, than exits
New positions opened: 456 | Existing positions closed: 88
60% more funds holding in top 10
Funds holding in top 10: 134 → 214 (+80)
41% more call options, than puts
Call options by funds: $4.58B | Put options by funds: $3.25B
40% more capital inflows, than outflows
Capital inflows: $7.94B | Capital outflows: $5.69B
39% more repeat investments, than reductions
Existing positions increased: 1,280 | Existing positions reduced: 921
12% more funds holding
Funds holding: 2,658 → 2,983 (+325)
0.97% more ownership
Funds ownership: 66.69% → 67.66% (+0.97%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$877M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$753M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$384M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$315M |
| 5 |
State Street
Boston,
Massachusetts
|
+$307M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$1.34B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$538M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$311M |
| 4 |
Orbis Allan Gray
Hamilton,
Bermuda
|
-$298M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$212M |
ABBV Hedge Fund Activity: Q4 2021 in Review
2,983 of the 6,522 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q4 2021, worth a combined $162B — up 27% from $127B a quarter earlier.
Buyers outnumbered sellers: 456 funds opened new ABBV positions and 88 closed out — a net gain of 368 holders — while 1,280 added to existing stakes and 921 trimmed.
The largest buyer was DZ Bank, adding an estimated $877M. The largest seller was Berkshire Hathaway, cutting an estimated $1.34B.
- 2,983 institutional investors held AbbVie (ABBV) as of Q4 2021, up from 2,658 in Q3 2021.
- Funds reported $162B of AbbVie stock for Q4 2021, up 27% quarter-over-quarter.
- 456 funds opened new AbbVie positions in Q4 2021 and 88 closed out, a net change of +368 holders.
- The largest AbbVie buyer in Q4 2021 was DZ Bank, an estimated $877M added.
- The largest AbbVie seller in Q4 2021 was Berkshire Hathaway, an estimated $1.34B sold.
Based on aggregated 13F filings for Q4 2021.